Zifibancimig

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zifibancimig, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]